Anteilseigner
Vivo Capital LLC (9,24 %) Tang Capital Management LLC (8,97 %) Pivotal Bioventure Partners Investment Advisor LLC (8,02 %) Sofinnova Investments, Inc. (7,22 %) Citadel Advisors LLC (6,21 %) Newtyn Management LLC (4,46 %) OrbiMed Advisors Private Equity (4,04 %) Edgar G. Engleman (3,20 %) Samsara Biocapital LLC (2,75 %) The Vanguard Group, Inc. (2,72 %) Stanford Management Co. (1,89 %) Toray Industries (1,88 %) Acuitas Investments LLC (1,36 %) Renaissance Technologies LLC (1,36 %) Adage Capital Management LP (1,31 %) Hawkeye Capital Management LLC (1,09 %) Geode Capital Management LLC (0,91 %) BlackRock Fund Advisors (0,66 %) Bridgeway Capital Management LLC (0,29 %) Marquette Asset Management LLC (0,25 %)
Kontakt
Bolt Biotherapeutics Inc.